Missing Data Workshop, 1-3 July, 1996: Missing quality of life data in cancer clinical trials: Serious problems and challenges

Statistics in Medicine

Volumn 17, Issue 5-7, 1998, Pages 517-532

  Bernhard, Jürg ^a   Cella, David F ^b   Coates, Alan S ^c   Fallowfield, Lesley ^d   Ganz, Patricia A ^e   Moinpour, Carol M ^f   Mosconi, Paola ^g   Osoba, David ^h   Simes, John ⁱ   Hürny, Christoph ^j  

^a SIAK Coordinating Center   (Switzerland)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER PATIENT; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; HUMAN; METHODOLOGY; QUALITY OF LIFE; STATISTICAL ANALYSIS; EPIDEMIOLOGY; INFORMATION PROCESSING; NEOPLASM; PSYCHOLOGICAL ASPECT; REVIEW;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; DATA COLLECTION; HUMANS; NEOPLASMS; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 2642683199     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19980315/15)17:5/7<517::AID-SIM799>3.0.CO;2-S     Document Type: Conference Paper

References (42)

1. Begg, C., Cho, M., Eastwood, S., Horton, R., Moher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. and Stroup, D. F. 'Improving the quality of reporting of randomized controlled trials: the CONSORT statement', Journal of the American Medical Association, 276, 637-639 (1996).
2. The Asilomar Working Group. 'Checklist of information for inclusion in reports of clinical trials', Annals of Internal Medicine, 124, 741-743 (1996).
3. Staquet, M., Berzon, R., Osoba, D. and Machin, D. 'Guidelines for reporting results of quality life assessments in clinical trials', Quality of Life Research, 5, 496-502(1996).
4. Fairclough, D. L., Peterson, H. F. and Chang, V. 'Why are missing quality of life data a problem in clinical trials of cancer therapy?' Statistics in Medicine, 17, 667-677 (1998).
5. Troxel, A. B., Fairclough, D. L., Curran, D. and Hahn, E. A. 'Statistical analysis of quality of life with missing data in cancer clinical trials', Statistics in Medicine, 17, 653-666 (1998).
6. Proceedings of the Workshop on missing data in quality of life research in cancer clinical trials: Practical and methodological issues, July 1996. Statistics in Medicine, (1997).
7. Finkelstein, D. M., Cassileth, B. R., Bonomi, P. D., Ruckdeschel, J. C., Exdinli, E. Z. and Wolter, J. M. 'A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study', American Journal of Clinical Oncology (CCT), 11, 630-633 (1988).
8. Ganz, P. A., Haskell, C. M., Figlin, R. A., La Soto, N. and Siau, J. 'Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer', Cancer, 61, 849-856 (1988).
9. Geddes, D. M., Dones, L., Hill, E., Law, K., Harper, P. G., Spiro, S. G., Tobias, J. S. and Souhami, R. L. 'Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial', European Journal of Cancer, 26, 484-492 (1990).
10. Hürny C., Bernhard, J., Joss, R., Willems, Y., Cavalli, F., Kiser, J., Brunner, K., Favre, S., Alberto, P., Glaus, A., Senn, H. J., Schatzmann, E., Ganz, P. and Metzger, U., for the Swiss Group for Clinical Cancer Research SAKK. 'Feasibility of quality of life assessments in a randomized phase III trial of small cell lung cancer - a lesson from the real world', Annals of Oncology, 3, 825-831 (1992).
11. Hayden, K. A., Moinpour, C. M., Metch, B., Feigl, P., O Bryan, R. M., Green, S. and Osborne, C. K. 'Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial', Oncology Nursing Forum, 20, 1415-1419 (1993).
12. Sadura, A., Pater, J., Osoba, D., Levine M., Palmer, M. and Bennett, K. 'Quality-of-life assessment; patient compliance with questionnaire completion', Journal of the National Cancer Institute, 84, 1023-1026 (1992).
13. Coates, A., Gebski, V., Bishop, J. F., Jeal, P. N., Woods, R. L., Snyder, R., Tattersall, M. H. N., Byrne, M., Harvey, V., Gill, G., Simpson, J., Drummond, R., Browne, J., v. Cooten, R. and Forbes, J. F. 'Improving the quality of life in advanced breast cancer. A comparison of continuous and intermittent treatment strategies', New England Journal of Medicine, 317, 1490-1495 (1987).
14. Coates, A. and Gebski, V. for the Australian New Zealand Breast Cancer Trials Group and the NHMRC Clinical Trials Centre. 'Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data', Statistics in Medicine, 17, 533-540 (1998).
15. Cella, D. F. and Bonomi, A. E. 'Measuring quality of life: 1995 update', Oncology (suppl), 9, 47-60 (1995).
16. Kiebert, G. M., Curran, D. and Aaronson, N. K. 'Quality of life as an endpoint in EORTC clinical trials', Statistics in Medicine, 17, 561-569 (1998).
17. Bernhard, J., Peterson, H. F., Coates, A. S., Gusset, H., Isley, M., Hinkle, R., Gelber, R. D., Castiglione-Gertsch, M. and Hürny, C., for the International Breast Cancer Study Group (IBCSG). 'Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data', Statistics in Medicine, 17, 587-601 (1998).
18. Osoba, D. and Zee, B. 'Completion rates in health-related quality-of-life assessment: Approach of the National Cancer Institute of Canada Clinical Trials Group', Statistics in Medicine, 17, 603-612 (1998).
19. Hahn, E. A., Webster, K. A., Cella, D. and Fairclough, D. L. 'Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions', Statistics in Medicine, 17, 547-559 (1998).
20. Nayfield, S. G., Ganz, P. A., Moinpour, C. M., Cella, D. F. and Hailey, B. J. 'Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials', Quality of Life Research, 1, 203-210 (1992).
21. Gotay, C. C., Korn, E. L., McCabe, M. S., Moore, T. D. and Cheson, B. D. 'Quality of life assessment in cancer treatment protocols: Research issues in protocol development', Journal of the National Cancer Institute, 84, 575-579 (1992).
22. Osoba, D. 'The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions', Quality of Life Research, 1, 211-218 (1992).
23. Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D. and Stephens, R. 'Quality of life assessment in clinical trials - guidelines and a checklist for protocol writers: The UK MRC experience', European Journal of Cancer, 33, 20-28 (1997).
24. Cella, D. F. and Lloyd, S. R. 'Data collection strategies for patient-reported information', Quality Management in Health Care, 2, 28-35 (1994).
25. Ganz, P. A., Day, R. and Costantino, J. 'Compliance with quality-of-life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial', Statistics in Medicine, 17, 613-622 (1998).
26. Moinpour, C. M. and Lovato, L. C. 'Ensuring the quality of quality of life data: the Southwest Oncology Group experience', Statistics in Medicine, 17, 641-651 (1998).
27. Bernhard, J., Gusset, H. and Hürny, C. 'Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research', Statistics in Medicine, 17, 633-639 (1998).
28. Fallowfield, L. 'Compliance issues in quality of life assessment: Experiences of two Cancer Research Campaign sponsored groups', Statistics in Medicine, 17, 541-546 (1998).
29. Mosconi, P., Torri, V., Cifani, S., Ruggiata, R., Meyerowitz, B. E., Apolone, G. and Liberati, A., on behalf of Interdisciplinary Group for Cancer Care Evaluation (GIVIO). 'The multicentre assessment of quality of life: the Interdisciplinary Group for Cancer Care Evaluation (GIVIO) experience in Italy', Statistics in Medicine, 17, 577-585 (1998).
30. Olschewski, M. 'Compliance with QOL assessment in multicentre German breast cancer trials', Statistics in Medicine, 17, 571-575 (1998).
31. Kaasa, S., Hjermstad, M. J., Jordhøy, M. S., Wisløff, F. and Loge, J. H. 'Compliance in quality of life data: A Norwegian experience', Statistics in Medicine, 17, 623-632 (1998).
32. Kornblith, A. B. and Holland, J. C. 'Model for quality-of-life research from the Cancer and Leukemia Group B: the telephone interview, conceptual approach to measurement, and theoretical framework', Journal of the National Cancer Institute Monogr., 20, 55-62 (1996).
33. Kornblith, A. B., Anderson, J., Cella, D. F., Tross, S., Zuckerman, E., Cherin, E., Henderson, E. S., Weiss, R. B., Cooper, M. R., Silver, R. T., Leone, L., Cancello, G. P., Gottlieb, A. and Holland, J. C. 'Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials', Oncology, 4, 93-101 (1990).
34. McHorney, C. A., Kosinski, M. and Ware, J. E. Jr. 'Comparisons of the costs and quality of norms for the SF-36 Health Survey collected by mail versus telephone interview: Results from a national survey', Medical Care, 32, 551-567 (1994).
35. Medical Research Council Lung Cancer Working Party. 'A randomized trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life', British Journal of Cancer, 68, 1157-1166 (1993).
36. Hürny, C., Bernhard, J., Coates, A., Castiglione, M., Peterson, H. F., Gelber, R. D., Rudenstam, C. M., Goldhirsch, A. and Senn, H. J., for the International Breast Cancer Study Group. 'Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation', Annals of Oncology, 5, 65-74 (1994).
37. Simes, R. J., Greatorex, V. and Gebski, V. J. 'Practical approaches to minimize problems with missing quality of life data', Statistics in Medicine, 17, 725-737 (1998).
38. Sprangers, M. A. G. and Aaronson, N. K. 'The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review', Journal of Clinical Epidemiology, 45, 743-760 (1992).
39. Thirlaway, K., Fallowfield, L. and Cuzick, J. 'The Sexual Activity Questionnaire: a measure of women's sexual functioning', Quality of Life Research, 5, 81-90 (1996).
40. Friedman, L. M., Furberg, C. D. and DeMets, D. L. Fundamentals of Clinical Trials, 3rd edn, Mosby-Year Book, Inc., St. Louis, Missouri, 1996.
41. Hopwood, P., Stephens, R. J. and Machin, D. 'Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial', Quality of Life Research, 3, 339-352 (1994).
42. Machin, D. and Weeden, S. 'Suggestions for the presentation of quality of life data from clinical trials', Statistics in Medicine, 17, 711-724 (1998).